metoclopramide has been researched along with Malignant Melanoma in 3 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Delayed emesis has not been seen during the antiemetic therapies." | 6.67 | [Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron]. ( Baki, M; Czeglédi, F, 1994) |
| "Metoclopramide was used as an antiemetic." | 5.26 | [Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)]. ( Antz, H; Doepfmer, K; FEAUX DE Lacroix, W; Groth, W; Runne, U, 1980) |
| "Delayed emesis has not been seen during the antiemetic therapies." | 2.67 | [Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron]. ( Baki, M; Czeglédi, F, 1994) |
| " Regimen B, employing a lower dosage of metoclopramide and steroids and using a more simple schedule of administration should be the preferred treatment." | 2.67 | Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients. ( Basurto, C; Boschetti, E; Bracarda, S; Del Favero, A; Lupattelli, M; Picciafuoco, M; Roila, F; Sassi, M; Tonato, M, 1992) |
| "Metoclopramide was used as an antiemetic." | 1.26 | [Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)]. ( Antz, H; Doepfmer, K; FEAUX DE Lacroix, W; Groth, W; Runne, U, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Runne, U | 1 |
| Doepfmer, K | 1 |
| Antz, H | 1 |
| Groth, W | 1 |
| FEAUX DE Lacroix, W | 1 |
| Czeglédi, F | 1 |
| Baki, M | 1 |
| Roila, F | 1 |
| Bracarda, S | 1 |
| Basurto, C | 1 |
| Sassi, M | 1 |
| Lupattelli, M | 1 |
| Picciafuoco, M | 1 |
| Boschetti, E | 1 |
| Del Favero, A | 1 |
| Tonato, M | 1 |
2 trials available for metoclopramide and Malignant Melanoma
| Article | Year |
|---|---|
[Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron].
Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Huma | 1994 |
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dexamethasone; Diphenhydramine; Double- | 1992 |
1 other study available for metoclopramide and Malignant Melanoma
| Article | Year |
|---|---|
[Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)].
Topics: Budd-Chiari Syndrome; Dacarbazine; Humans; Male; Melanoma; Metoclopramide; Middle Aged; Mycobacteriu | 1980 |